In pancreatic cancer cells, TRIM31 has been shown to upregulate nuclear P65 levels and sustain NF-κB activation by promoting K63-linked polyubiquitination of tumor necrosis factor receptor-associated factor 2 (TRAF2) [34]. This evidence concerns the gene NFKB1 and pancreatic neoplasm.